While Merck’s PAH treatment…
While Merck’s PAH treatment Winrevair continued its upward trajectory, another [...]
While Merck’s PAH treatment Winrevair continued its upward trajectory, another [...]
As AstraZeneca braces for the impact of the U.S. “most [...]
While Teva Pharmaceutical’s multiyear growth streak under CEO Richard Francis [...]
Immunology med Skyrizi charted sales growth of 30.9% over 2026’s [...]
Novartis CEO Vas Narasimhan says that Europe needs a “complete [...]
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” [...]
The FDA has told Amgen that it is proposing to withdraw [...]
Mundipharma and CorMedix have announced a win for their antifungal [...]
Eleventh-hour settlements with two of the three generic drugmakers involved [...]
Haleon, a healthcare consumer and OTC brand company, has hired [...]